Illinois Research and Development Tax Credit: A Comprehensive Guide to Schedule 1299-D Compliance and Maximization

Executive Summary

This report provides a definitive analysis of the Illinois Research and Development (R&D) Tax Credit (35 ILCS 5/201(k)), focusing on the statutory and regulatory requirements for claim administration via Illinois Schedule 1299-D. The R&D credit is a vital, non-refundable incentive valued at 6.5% of incremental Qualified Research Expenditures (QREs) incurred within the state, calculated using a three-year average base period methodology. The analysis details the stringent compliance steps mandated by the Illinois Department of Revenue (IDOR), emphasizing the required calculation inputs derived from Schedule 1299-I, and offers strategic guidance for mitigating audit risk related to expense substantiation and base integrity. Legislative action extending the credit through 2031 has solidified its role as a cornerstone of Illinois’s long-term economic strategy.

I. Introduction: Contextualizing Schedule 1299-D

A. The Simple Meaning of Schedule 1299-D

Schedule 1299-D (Income Tax Credits for Corporations and Fiduciaries) is the mandated Illinois tax form used by corporations, certain fiduciaries, and exempt organizations filing income tax returns to summarize and apply various state credits earned.

This schedule is essential for tracking both the current year’s earned credits and any unused credit amounts carried forward from previous taxable years.1

B. Purpose and Scope of the Illinois R&D Credit

The Illinois Research and Development Credit (R&D Credit, Code 5340) is established under the Illinois Income Tax Act (35 ILCS 5/201(k)) to encourage businesses to invest in high-value, innovative activities performed within the state.3 This incentive is a critical component of Illinois’s strategy to promote growth in technology, manufacturing, and other research-intensive sectors.3

The credit is a non-refundable incentive 1, meaning it can only offset an existing Illinois income tax liability and cannot generate a cash refund. The credit is calculated at a rate of 6.5% of the incremental QREs.1 Entities eligible to claim the credit via Schedule 1299-D include C-Corporations filing Form IL-1120, Fiduciaries filing Form IL-1041, and Exempt Organizations filing Form IL-990-T for unrelated business income.2 Flow-through entities, such as partnerships and S corporations, compute and pass the credit through to their owners using Schedule 1299-A.1 A significant benefit of the credit is the provision that any unused credit amount may be carried forward for utilization over the next five taxable years.1 Schedule 1299-D serves as the formal mechanism for managing this five-year carryforward period.

C. Legislative Stability: The Strategic Extension of the Credit

The continuity of the Illinois R&D tax credit has recently been secured through pivotal state legislation. The credit was previously subject to sunset clauses (e.g., expiration on December 31, 2021, noted in earlier periods 1). However, in accordance with Public Act 103-0595, the R&D tax credit has been definitively extended until tax years ending on or before December 31, 2031.3

This significant extension transforms the R&D credit from a potentially temporary or unreliable benefit into a stable, long-term component of corporate financial planning. For businesses requiring extensive, multi-year capital investment—such as those in quantum computing, electric vehicles, and clean energy (sectors the state has actively targeted for growth 7)—tax policy stability is paramount. The long-term commitment signaled by the 2031 extension minimizes regulatory risk, strongly encouraging companies to site and expand high-wage R&D infrastructure and job creation within Illinois, knowing the tax incentive will remain a viable factor in their capital expenditure projections for the next decade.

II. Statutory and Regulatory Foundation (35 ILCS 5/201(k))

The eligibility criteria for the Illinois R&D credit are tightly bound to the definitions established in the federal Internal Revenue Code (IRC), specifically Sections 41(d) and 41(e), ensuring alignment with national standards for qualified research.8

A. Definition of Qualified Research Expenses (QREs)

Qualified Research Expenses (QREs) generally encompass costs associated with research conducted in-house and through contracts, which includes the sum of three primary components: in-house research expenses, contract research expenses (65%), and basic research payments.8 For Illinois purposes, these expenses specifically include wages disbursed to employees actively involved in performing, directly supervising, or directly supporting qualified research activities.3 They also include the costs of supplies used in the conduct of research and certain costs related to the rental or lease of computers utilized in research.3 It is fundamental that only those QREs associated with activities performed within Illinois are includible in the calculation for the state credit.1

B. The Four-Part Test for Qualified Research Activities

To ensure expenses meet the stringent requirements of “qualified research,” the activities generating the QREs must satisfy a four-part test consistent with federal standards. The activity or project must demonstrate the following 8:

1. Permitted Purpose: The objective of the activity must be to create new functionality or achieve improvements in the performance, reliability, or quality of a business component, whether new or existing.1
2. Elimination of Uncertainty: The research must be intended to discover information that would effectively eliminate technical uncertainty regarding the appropriate design, method, capability, or process required for the development or improvement of the business component.1
3. Technological in Nature: The activities must rely fundamentally on the principles of physical science, biological science, engineering, or computer science to resolve the technical uncertainties.4
4. Experimentation Element: The research process must involve a systematic trial-and-error process, testing, modeling, or other forms of rigorous experimentation to achieve the desired outcome.4

C. Distinguishing Illinois-Sourced QREs

For businesses that operate in multiple jurisdictions, the precise sourcing of QREs to Illinois is a critical compliance checkpoint. While the R&D credit is based on federal definitions, the state incentive is explicitly limited to QREs generated by activities performed within Illinois.1 This means that the wages, supplies, and contract research payments must be apportioned or directly attributed to qualified research services conducted inside the state boundaries.3

Because the Illinois R&D tax credit is incremental, the integrity of the Illinois QRE calculation is non-negotiable. The IDOR consistently finds general compliance issues among taxpayers related to the over-reporting of expenses and the claiming of improper business deductions.9 This administrative focus translates directly into heightened scrutiny for multi-state companies claiming R&D credits. Auditors will closely examine the documentation supporting the geographic allocation of QREs, particularly payroll expenses, to ensure that QREs are not disproportionately allocated to Illinois merely to maximize the state credit. Therefore, rigorous, detailed payroll time tracking and comprehensive support documenting the physical location where the research services were performed are essential for defensibility in the event of an IDOR audit.

III. The Incremental Calculation Model and Base Determination

The Illinois R&D credit employs an incremental methodology, which incentivizes businesses to increase their current research spending above historical levels.

A. Overview and Calculation Formula

The mechanism for calculating the credit closely mirrors the federal Alternative Simplified Method (ASM).3 The credit is not based on total QREs but only on those expenses that exceed a predetermined base amount.5

The determination of the credit is formalized by the following relationship:

$$\text{Credit} = 6.5\% \times (\text{Current Year Illinois QREs} – \text{Average Base QREs})$$

If the current year’s QREs are less than the calculated base amount, no credit is available for that taxable year.

B. Defining the Base Period QREs

The base amount serves as the benchmark against which the current year’s QREs are measured.

The Three-Year Lookback Rule

The base amount is calculated as the arithmetic average of the Illinois QREs incurred during the three taxable years immediately preceding the taxable year for which the credit is being determined.4 For example, determining the credit for Tax Year 4 requires averaging QREs from Tax Years 1, 2, and 3.8

Special Rules for New or Inactive Companies

• Zero Expenditure Years: If a taxpayer had no QREs during one or more of the three base period years, the qualifying expenditures for that year are counted as zero in the calculation of the base average.3 This provision is particularly beneficial for startups or entities initiating R&D activities in Illinois, as a zero base amount maximizes the incremental credit calculation, potentially allowing the credit to apply to 6.5% of the entire current year’s QREs.3
• Mandatory Inclusion: Conversely, QREs incurred in base period years in which the taxpayer did not actually claim the credit (including periods when the credit was not in effect) must still be included in the computation of the base period.11
• Proration for Partial Years: If a taxpayer was doing business in Illinois for only a portion of a base period year, the QREs incurred during that year must be annualized for the calculation. The actual QREs incurred are multiplied by 365 and then divided by the number of days the taxpayer conducted business in Illinois during that period.11

Rules Governing Corporate Restructuring (IITA Section 405(a))

A critical regulatory provision exists regarding corporate structure changes. According to administrative guidance (86 Ill. Admin. Code 100.2160), if a taxpayer succeeds to the tax items of a predecessor corporation under IITA Section 405(a), the predecessor corporation’s qualifying expenditures incurred during the base period are automatically attributed to, and deemed the QREs of, the successor taxpayer.11

This administrative requirement serves as an anti-abuse mechanism. It prevents a corporation from executing certain types of mergers, acquisitions, or restructuring solely to artificially “cleanse” its R&D tax history. If the historical QRE base were not carried over, a successor entity could potentially claim zero QREs in the base period, maximizing the incremental credit immediately after the acquisition. By mandating the carryover of the historical base, the state ensures that the credit remains true to its legislative intent of incentivizing increased research activity, rather than merely subsidizing existing activity through corporate tax planning. Tax professionals involved in due diligence for corporate successions must ensure that comprehensive documentation of the predecessor’s QREs is secured, as this historical data is legally binding on the successor for base calculation purposes.

C. Carryforward Mechanics

The Illinois R&D credit is non-refundable.3 If the calculated credit exceeds the current year’s income tax liability, the taxpayer cannot receive a direct refund. Instead, the unused portion of the credit may be carried forward for a period of up to five subsequent taxable years.1 Schedule 1299-D is the official record-keeping document used to track and apply these carryforward amounts in succeeding tax years.2

IV. IDOR Compliance and Filing Mechanics: Schedule 1299-D and 1299-I

Successful claiming of the R&D credit requires precise coordination between the calculation worksheet (Schedule 1299-I) and the application form (Schedule 1299-D).

A. Schedule 1299-D: The Application and Summary Document

Schedule 1299-D is required for corporations (IL-1120), fiduciaries (IL-1041), and exempt organizations (IL-990-T) entitled to any credits listed on Schedule 1299-I.2 This schedule must be completed even if the earned credits are not utilized to offset the current year’s tax liability, as it initiates the carryforward period.2

• Combined Unitary Returns: When an Illinois combined unitary return is filed, only one Schedule 1299-D must be completed for the entire combined group.2
• Aggregation: If a taxpayer receives more than one eligible credit of the same code and expiration date (e.g., from multiple K-1-Ps), the amounts must be added together and the total entered on the corresponding line in Column F (Credit Amount Earned) of Schedule 1299-D, Step 3.2
• Rounding Requirement: A specific mechanical requirement of the IDOR forms is that all dollar amounts on Schedule 1299-D (and 1299-I) must be rounded to the nearest whole dollar. Amounts less than 50 cents must be dropped, and amounts of 50 cents or more must be rounded up to the next higher dollar.2

B. The Mandatory Role of Schedule 1299-I (Worksheet)

Schedule 1299-I, titled “Income Tax Credits Information and Worksheets,” is an integral component of the R&D claim process. Before entering any R&D credit earned in the current year onto Schedule 1299-D, the taxpayer must complete the Research and Development Worksheet contained within Schedule 1299-I.2

Schedule 1299-D is primarily an application ledger for the credit; Schedule 1299-I provides the step-by-step formula that determines the exact credit amount earned (Column F on 1299-D).2 This calculation worksheet is the foundational audit trail for the R&D claim. The IDOR requires taxpayers to keep a copy of the completed Schedule 1299-I in their records, as they may be required to submit it for verification during correspondence or an audit.2 The accuracy and completeness of Schedule 1299-I directly validates the mathematical soundness of the credit claimed on Schedule 1299-D.

C. Required Documentation and Consequences of Failure

Compliance dictates that taxpayers attach specific forms and supporting evidence to their return, depending on the credits claimed. While the R&D credit itself does not require external certification from a body like DCEO, the general instructions for Schedule 1299-D require attaching, if applicable 2:

• Schedule(s) K-1-P received from partnerships or S corporations that passed through the credit.
• Certificates issued by state departments for other applicable credits (e.g., DCEO, DNR, DHS).
• Any required transfer documentation.
• The instructions found in Schedule 1299-I provide specific information about what, beyond the worksheet, must be attached to support the 1299-D filing.2

The IDOR is explicit regarding the consequences of non-compliance: failure to adhere strictly to instructions and attach all required documentation will result in a delay in the processing of the tax return, potential disallowance of the claimed credit, or the issuance of correspondence requesting further information.2

V. IDOR Administrative Scrutiny and Risk Mitigation

Proactive planning for a potential IDOR audit is mandatory for any corporation claiming the R&D credit.

A. Persistent Audit Focus Areas

Auditors frequently find recurring issues among taxpayers that are highly relevant to R&D credit claims, including: over-reporting of expenses, claiming disproportionately large expenses relative to reported income, and claiming improper business deductions.9 For the R&D credit specifically, these general issues manifest as targeted audit risks:

1. Qualification of Activities: IDOR scrutiny focuses on whether QREs are linked to activities that fail the four-part test (e.g., general management activities, routine quality control, or market research, which are non-qualified activities).14 Claims must be supported by evidence that the activity was technological in nature and intended to eliminate technical uncertainty.8
2. Base Amount Substantiation: The incremental nature of the credit makes the base calculation the foundation of the claim. If the taxpayer cannot provide adequate support to prove the qualifying expenditures for the three base period years, the IDOR may view the fixed-base percentage calculation as unsubstantiated, which can result in a complete disallowance of the entire credit claimed.15

B. Requirements for Contemporaneous Documentation

Defense against disallowance requires comprehensive, contemporaneous documentation that explicitly ties the expenses to the qualifying research activities. Taxpayers must maintain records that include project narratives detailing the technical uncertainty and the systematic process of experimentation used to resolve it.1 Furthermore, the taxpayer must retain a copy of both the completed Schedule 1299-D and, critically, Schedule 1299-I in their records. Because the base calculation utilizes expenses from up to three prior years and the carryforward spans five years, documentation supporting R&D claims must be retained for significantly longer than the typical three-year tax statute of limitations.2

C. IDOR Contact Information

Taxpayers requiring assistance, forms, or schedules regarding income tax credits can utilize the resources provided by the Illinois Department of Revenue 2:

• Website: tax.illinois.gov
• Mailing Address: ILLINOIS DEPARTMENT OF REVENUE, PO BOX 19001, SPRINGFIELD IL 62794-9001

VI. Practical Example: Schedule 1299-D R&D Credit Determination

The following example illustrates the calculation of the Illinois R&D credit for a corporation and demonstrates its application to Schedule 1299-D.

A. Case Study Scenario and Historical Data

Innovate IL Corp. (a corporation filing Form IL-1120) is determining its R&D credit for Tax Year 4. All QREs listed are strictly limited to activities performed in Illinois.

Innovate IL Corp.: Illinois QRE History and Base Determination

B. Detailed Calculation of the Credit Earned (Schedule 1299-I Worksheet)

The calculation follows the incremental methodology 3:

The final amount of $58,500 is the Credit Amount Earned that will be reported in Column F of Schedule 1299-D, Step 3.

C. Mapping the Final Credit onto Schedule 1299-D, Step 3

Assume Innovate IL Corp. has a current Illinois Income Tax Liability of $75,000. After applying a mandatory credit of $15,000 (e.g., Enterprise Zone Investment Credit) in Sequence Line 1, the remaining tax liability is $60,000.

Excerpt from Schedule 1299-D, Step 3: Application of R&D Credit

• Application Analysis: The remaining tax liability before applying the R&D credit is $60,000. The R&D credit available is $58,500 (Column D). Since the available credit is less than the remaining liability, the full $58,500 is applied (Column E).
• Updated Scenario (Illustrative Carryforward): Had the remaining tax liability been only $40,000, the company would enter $40,000 in Column E (Credit Applied). The excess of $18,500 ($58,500 earned minus $40,000 applied) would then be tracked in Step 4 of Schedule 1299-D for carryforward over the next five years.1

VII. Strategic Considerations and Economic Outlook

A. State Policy Objective and Economic Impact

The Illinois R&D credit is strategically vital to the state’s economic development, designed to specifically foster investment in advanced industries such as quantum computing, electric vehicles, and ag tech.7 By adopting the incremental model (6.5% of QREs exceeding the base), the state ensures that the tax expenditure directly incentivizes net new economic activity and research spending, rather than simply subsidizing pre-existing business operations.

B. Utilization and Growth Trends

The R&D credit constitutes a notable tax expenditure for the state. According to the Illinois Fiscal Year 2022 Tax Expenditure Report (derived from Tax Year 2020 corporate data), the corporate income tax expenditure attributed to the Research and Development Credit totaled $46,738 thousand.16 This substantial amount was distributed across various state funds, including the General Revenue Fund and the Education Assistance Fund.16

Furthermore, the reported utilization of the credit demonstrated significant growth, with expenditures for the Research and Development Credit increasing by 18.2% in Fiscal Year 2022 compared to the preceding fiscal year.16 This high growth rate confirms that the tax incentive is effective in its role as an economic stimulus, driving a measurable increase in incremental Qualified Research Expenditures within Illinois corporations. Such quantitative results justify the legislature’s decision to extend the credit through 2031, providing a necessary return on the state’s investment in innovation.

C. Interaction with Other Tax Limitations

Taxpayers claiming the R&D credit must consider its interaction with other provisions of the Illinois Income Tax Act. Notably, the state implemented a temporary Net Operating Loss (NOL) deduction limitation. For taxable years ending on or after December 31, 2024, and prior to December 31, 2027, the amount a taxpayer can deduct for its NOL is limited to $500,000.17

The limiting of the NOL deduction results in a higher overall Illinois taxable income base during this period. For non-refundable credits like the R&D credit, a higher taxable income base translates to a larger capacity to absorb the available credit in the current year. Consequently, this NOL limitation may strategically benefit businesses claiming R&D credits by reducing the reliance on the five-year carryforward provision, thereby increasing the likelihood of maximizing the credit’s immediate benefit.

VIII. Conclusion and Expert Recommendations

Schedule 1299-D is the essential tax form for corporations and fiduciaries to finalize and apply the Illinois R&D Tax Credit. With the credit now secured through December 31, 2031, its strategic value has substantially increased, requiring corporations to treat R&D claims as a long-term element of their tax compliance portfolio.

To successfully navigate IDOR requirements and maximize the benefit of the 6.5% incremental credit, compliance efforts must focus on two critical areas:

1. Integrity of the Calculation: Accurate determination of the credit hinges on the meticulous completion of Schedule 1299-I. This involves correctly calculating the three-year base period average, securing predecessor QRE data in M&A scenarios, and ensuring all QREs strictly meet the four-part test for qualified research and are properly sourced to Illinois.
2. Audit Preparedness: Given IDOR’s focus on expense substantiation, corporations must maintain contemporaneous documentation that proves the technical qualifications of the research and precisely supports the QREs claimed for the current year and the QREs used in the base period calculation. Failure to produce the supporting Schedule 1299-I and underlying documentation will inevitably lead to processing delays or complete disallowance of the credit.

By adhering to these rigorous reporting and substantiation standards, taxpayers can confidently leverage the R&D tax credit as a reliable component of their Illinois tax minimization strategy.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/